ArticlePharmaceuticals (Basel, Switzerland)2026

IL-33-Driven Macrophage Reprogramming as a Potential Immunometabolic Strategy for Herpes Simplex Keratitis.

Yun He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.